Psychiatry Medical News about antipsychotics • prescribing trends • general population

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Omega-3 fatty acids for bipolar disorder

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ginkgo biloba: specificity of neuropsychological improvement - a selective review in search of differential effects
Human Psychopharmacology: Clinical and Experimental, 06/30/09

Verdoux H. et al -Considering the growing number of persons from the general population exposed to APs, population studies assessing the risk/benefit ratio of SGAP use in disorders other than psychosis are necessary, particularly in children and adolescents.

Methods

Retrieved original studies that explored AP prescribing trends in general population samples since 2000.
For each study, we extracted information on sampling method, period, assessment of AP use and corresponding estimates (incidence rates, prevalence rates, pharmacy sales, prescription data) and diagnostic assessment.

Results

Nearly all studies meeting the inclusion criteria (n = 17) showed an increase in AP prescriptions, mainly because of a dramatic rise in second-generation antipsychotics (SGAP) prescriptions.
APs are often prescribed for non-psychotic disorders in adults as well as in children and adolescents.

<< Previous
Comparison of health care use and costs in newly diagnosed and...

Next >>
Binge drinking and depressive symptoms: a 5-year population-based...